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ABSTRACT
Telomerase is a ribonucleoprotein enzyme that
maintains chromosome ends through de novo
addition of telomeric DNA. The ability of telomerase
to interact with its DNA substrate at sites outside its
catalytic centre (‘anchor sites’) is important for its
unique ability to undergo repeat addition processiv-
ity. We have developed a direct and quantitative
equilibrium primer-binding assay to measure DNA-
binding affinities of regions of the catalytic protein
subunit of recombinant Tetrahymena telomerase
(TERT). There are specific telomeric DNA-binding
sites in at least four regions of TERT (the TEN, RBD,
RT and C-terminal domains). Together, these sites
contribute to specific and high-affinity DNA binding,
with a Kd of  8nM. Both the Km and Kd increased in
a stepwise manner as the primer length was
reduced; thus recombinant Tetrahymena telomer-
ase, like the endogenous enzyme, contains multiple
anchor sites. The N-terminal TEN domain, which has
previously been implicated in DNA binding, shows
only low affinity binding. However, there appears to
be cooperativity between the TEN and RNA-binding
domains. Our data suggest that different DNA-
binding sites are used by the enzyme during
different stages of the addition cycle.
INTRODUCTION
Telomeres form a protective cap on the ends of chromo-
somes and are composed of short G-rich DNA repeats
bound by sequence-speciﬁc proteins (reviewed in 1).
The telomeres of unicellular eukaryotes and of the germ
cells of multicellular organisms are maintained by the
ribonucleoprotein enzyme telomerase, which was ﬁrst
identiﬁed in the ciliated protozoan Tetrahymena thermo-
phila (2). Telomerase activity has been detected in  90%
of human cancers, providing a telomere maintenance
mechanism that is necessary for their unlimited growth
(3–5).
The protein catalytic subunit of telomerase, telomerase
reverse transcriptase (TERT, ref. 6), contains protein
motifs that are conserved with other reverse transcriptases
(‘RT motifs’) and motifs in its amino terminal region
that are conserved among TERTs from diﬀerent species.
A deﬁned region of the telomerase RNA subunit is used as
the template for addition of DNA repeats onto telomeres
(7). A complex consisting of TERT and telomerase RNA
is suﬃcient to reconstitute in vitro telomerase activity from
Tetrahymena and human enzymes, measured by proces-
sive extension of a DNA oligonucleotide with telomere
repeats (8,9). The repeated copying of a short segment of
RNA, followed by translocation to the beginning of this
sequence, leads to the unique property of telomerase
known as ‘repeat addition processivity’. While in vitro
activity of the recombinant enzyme is robust, recombinant
Tetrahymena telomerase is less processive than its
endogenous counterpart (9,10).
The interactions of telomerase with its DNA substrate
have been studied using puriﬁed telomerase from
Tetrahymena extracts. High concentrations of short
oligonucleotide primers (<10nt) were required to achieve
eﬃcient extension (11,12). For longer oligonucleotides,
primer aﬃnity, as measured by activity (Km), varied with
diﬀerent sequences at the 50 end of the primer (11).
Telomerase was able to extend a non-telomeric primer
bearing telomeric sequences at its 50 end with nanomolar
aﬃnity (13). Sequences at the 50 end of the primer also
aﬀected the processivity of endogenous human telomerase
(14). These observations led to the proposal that
telomerase contains a DNA-binding site outside the
template region, called the ‘anchor site’ (12,14). It was
proposed that the anchor site is necessary for repeat
addition processivity, by allowing the enzyme to remain
bound to the 50 end of its DNA substrate during
translocation. Thus, in order to fully understand the
unique mechanism of telomerase, it is necessary to know
more about the nature of the anchor site.
There is evidence for telomerase from several species
that there are multiple sites of interaction with diﬀerent
regions of the primer (11,15–17). For example, the aﬃnity
of endogenous Tetrahymena telomerase for DNA
decreased in a stepwise manner as the primer was reduced
in length from 12 to 10nt then 6nt (11), and two 50 regions
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These diﬀerent sites have been dubbed the ‘template-
proximal’ and ‘template-distal’ anchor sites (17). For
Tetrahymena at least, it is possible that there are even
more distal sites of interaction between DNA and protein,
which may be important for binding to non-telomeric
sequences (18). While both the template-proximal and
template-distal anchor sites have an eﬀect on repeat
addition processivity (14,17,19), the fact that both
recombinant and endogenous Tetrahymena telomerase
can extend even primers as short as 4nt with reasonable
processivity shows that neither is absolutely necessary for
this property (19, our unpublished data).
Although evidence for direct interactions with the
TERT protein have been obtained by DNA crosslinking
to telomerase from Tetrahymena, the ciliate Euplotes
aediculatus and yeast (20–24), it is unclear which anchor
sites reside in the TERT protein and which are provided
by other members of the enzyme complex. There is some
evidence from activity-based assays for interactions of
DNA with various regions of TERT. Deletion of the
TERT-speciﬁc C-terminal extension of yeast TERT led to
a modest ( 2-fold) decrease in primer-binding aﬃnity
(25); the fact that mutations in this region in human
TERT led to a moderate decrease in repeat addition
processivity suggests that this function may be conserved
among species (26). A mutation in a TERT-speciﬁc region
of the RT domain reduced repeat addition processivity
of yeast telomerase, suggesting that this region may
also interact with DNA (27).
Recently, evidence has been presented that a region
within the N-terminal 200 amino acids of TERT (known
as the GQ or TEN domain) may be involved in anchor site
interactions. This region of TERT has the ability to form a
soluble, protease-resistant, independently folded structure
(24,28,29). Complementation studies with fragments of
human TERT indicate that this region (together with an
adjacent linker domain) can interact in trans with the rest
of the TERT protein (30–32). There may, however, be
species diﬀerences in the function of this domain, since
its removal leads to a loss of processivity of human
telomerase (32,33) but a complete loss of activity of
Tetrahymena telomerase (29,34).
A mutation in the TEN domain of yeast TERT led to
altered utilization of primers with non-telomeric 50 ends
(22). A mutation within this region in human TERT
caused a slight decrease in aﬃnity for a 9nt primer but not
an 18nt primer, indicating that this part of TERT may
interact with the 9nt at the 30 end of the primer (17).
Human TERT proteins containing mutations in this
region were also defective in elongation of telomeric
primers (35). Direct evidence for the involvement of this
region in DNA binding was provided by the demonstra-
tion that mutations in this region in Tetrahymena TERT
led to decreased crosslinking to a primer containing
5-iodo-deoxyuridine (5-iodo-dU) substitutions at its 50
end (24), and the site of crosslinking to a short primer was
mapped to a particular amino acid within TEN (W187)
(23). Finally, a fragment of human TERT encompassing
TEN bound to a biotinylated primer, though in a
non-sequence-speciﬁc manner (36).
While these studies provide an informative start in
understanding telomerase–DNA interactions, they do not
address relative contributions from the diﬀerent regions
of the TERT protein. To directly and quantitatively
measure binding aﬃnities of deﬁned regions of TERT,
we developed an activity-independent assay for primer
binding to recombinant Tetrahymena telomerase. We used
this direct equilibrium binding assay, in combination with
UV crosslinking, to assess primer aﬃnities of domains
of the TERT protein. Since the assay is independent of
activity, we were also able to use it to assess the level
of RNA-independent binding of DNA to TERT, bearing
in mind that such binding may not be identical to that in
the intact enzyme. These quantitative studies provide new
insights into the complexity of the telomerase anchor site.
MATERIALS AND METHODS
Plasmids and oligonucleotides
The construction of a synthetic Tetrahymena thermophila
TERT gene and its insertion into a pET-28 plasmid
encoding an N-terminal FLAG tag and a T7 promoter
have been previously described (10,37). A version of
this plasmid containing a BamHI site between the FLAG
tag and TERT was constructed in order to simplify
subsequent cloning steps. This plasmid (FLAG-Bam-
TERT) was made with site-directed mutagenesis using
the Quick Change II kit (Stratagene) according to the
manufacturer’s instructions. To construct a plasmid
encoding FLAG-tagged amino acids 1–519 of TERT
(plasmid FLAG-N519), this fragment was ampliﬁed using
primers 50-GTCGCAGGCGTCTGTTTGAATCAGTA
CTTTTC TGTC (forward) and 50-CAGGATCTCGAG
TCACAATTTTTCTTCCACTTTCTC (reverse), digested
with ScaI and XhoI and cloned into the ScaI and XhoI
sites of FLAG-TERT. To construct a plasmid encoding
FLAG-tagged amino acids 520-1117 of TERT (plasmid
FLAG-C598), this fragment was ampliﬁed using primers
50-GATATACCATGGCTGACTACAAGGACGACGA
TGACAAGCATATGGGGGGATCCATCCCAGAAG
ATTCATTTCAG (forward) and 50-CAGTGTCTTAAT
GTCCTGTATGAGGTTATTTAAATCTATGAATTC
AATAGCCTCCAGTTCTTTTTTGTTCAGCTG
(reverse), digested with NcoI and EcoRI and cloned into
the NcoI and EcoRI sites of FLAG-TERT. To construct a
plasmid encoding FLAG-tagged amino acids 192–519 of
TERT (plasmid FLAG-RBD), this fragment was ampli-
ﬁed using primers 50-CATATGGGGGGATCCTTTAA
TATGAACGGGAAAGCT (forward) and 50-CAGGAT
CTCGAGTCACAATTTTTCTTCCACTTTCTC
(reverse), digested with BamHI and XhoI and cloned
into the BamHI and XhoI sites of FLAG-Bam-TERT.
To construct a plasmid encoding FLAG-tagged amino
acids 1–884 of TERT (plasmid FLAG-C233), this frag-
ment was ampliﬁed using primers 50-GCACTGAATCTG
ATTGTACAACTCCAGAACTGTGCAAAC (forward)
and 50-CAGGATCTCGAGTCAGTTCATGTCGATGC
TTTTCCC (reverse), digested with BsrGI and XhoI and
cloned into the BsrGI and XhoI sites of FLAG-
Bam-TERT. pET-28 plasmids containing amino acids
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GQ) were a kind gift from Drs Thomas Cech and Steven
Jacobs at the University of Colorado, Boulder, CO, USA
(29). To construct a plasmid encoding FLAG-tagged
amino acids 2–191, the TEN/GQ plasmid was digested
with NdeI and BlpI and cloned into the NdeI and BlpI
sites of FLAG-TERT. For a FLAG-tagged version of
TEN, the TEN plasmid was digested with BamHI and
XhoI and cloned into the BamHI and XhoI sites of
FLAG-Bam-TERT. A plasmid encoding FLAG-tagged
amino acids 1–1094 of TERT (plasmid FLAG-C23) was
made by site-directed mutagenesis (Quick Change II kit,
Stratagene) of FLAG-Bam-TERT using the primers
50-CTGGAGGCTATTGAATTCATAGATTTAAATTA
ACTCATACAGGAC (forward) and 50-GTCCTGTAT
GAGTTAATTTAAATCTATGAATTCAATAGCCTC
CAG (reverse).
All oligonucleotides were purchased from Sigma-
Genosys. PCR primers were desalted by the manufacturer,
while the oligonucleotides listed in Table 1 were gel
puriﬁed on 20% polyacrylamide/8M urea gels before use.
Invitro translation and purification of Tetrahymena
telomerase
Tetrahymena telomerase RNA was transcribed in vitro
from the plasmid pTET-telo (38) as described previously
(10). The RNA was gel-puriﬁed before inclusion in in vitro
translation reactions using the plasmids described above
to translate TERT protein or fragments thereof.
Translations were carried out using the TnT T7 Quick
for PCR rabbit reticulocyte lysate system (Promega) as per
the manufacturer’s instructions. Translations included
20ng/ml plasmid DNA, 0.8mCi/ml[
35S]methionine and
20nM telomerase RNA.
In vitro reconstituted telomerase was puriﬁed by
immunoprecipitation with anti-FLAG M2 aﬃnity agarose
beads (Sigma-Aldrich). Beads (100ml) were washed four
times in 1.3ml of wash buﬀer-100 (20mM Tris acetate, pH
7.5, 10% glycerol, 1mM EDTA, 5mM MgCl2, 0.1mM
dithiothreitol [DTT], 100mM potassium glutamate),
centrifuging at 1500 g for 2min at 48C between
washes. The beads were incubated twice with 1ml of
blocking buﬀer [wash buﬀer-100 plus 0.5mg/ml lysozyme,
0.5mg/ml bovine serum albumin (BSA), 0.05mg/ml
glycogen, 0.1mg/ml yeast RNA] for 15min at 48C with
agitation. Reticulocyte lysate translation reaction (400ml)
was added to 400ml of blocking buﬀer and centrifuged at
16000 g for 10min at 48C to remove any particulates.
The supernatant from that spin was added to the blocked
beads and agitated at 48C for 2h. The beads were washed
four times in 1.3ml of wash buﬀer-300 (the same as wash
buﬀer-100 except with 300mM potassium glutamate),
twice in TMG (10mM Tris acetate pH 8.0, 10% glycerol,
1mM MgCl2) and once in wash buﬀer-0 (the same as wash
buﬀer-100 except with no potassium glutamate). For all
experiments except those in Figure 1, telomerase was
eluted from the beads by competition with a 3  FLAG
peptide (Sigma-Aldridge). The beads were resuspended in
200ml of peptide (0.75mg/ml) in wash buﬀer-0 in a Protein
LoBind tube (Eppendorf). BSA (New England Biolabs)
was added (0.5mg/ml) to prevent telomerase from sticking
to the tube after elution. The bead slurry was rotated at
48C for 1h, centrifuged at 1500 g for 2min at 48C and
the eluate removed to a fresh LoBind tube. Eluted
telomerase had  3–4-fold greater aﬃnity (Km) for its
DNA primer than did bead-bound telomerase (data not
shown), presumably reﬂecting a faster on-rate.
The yield of active enzyme was determined by dot
blotting an aliquot of the enzyme along with a dilution
series of Tetrahymena telomeric RNA onto a Hybond N+
membrane (Amersham Biosciences/GE Healthcare) and
detecting the RNA in the telomerase complex by hybridiz-
ing the membrane with a radioactive probe complementary
to Tetrahymena telomerase RNA (50-TATCAGCACTA
GATTTTTGGGGTTGAATG-30). The ﬁnal concentra-
tion of eluted telomerase was 7–9nM.
In vitro telomerase activity assay
Activity of recombinant telomerase was measured by
incubating 5ml of eluted telomerase in a 10ml reaction
including 1  Telomerase buﬀer (50mM Tris–Cl, pH 8.3,
1.25mM MgCl2, 5mM DTT), 100mM dTTP and 10mM
[a-
32P]dGTP at 80Ci/mmol (0.2ml of non-radioactive
dGTP at 487mM and 0.8mlo f[ a-
32P]dGTP at 10mCi/ml,
3000Ci/mmol; PerkinElmer Life Sciences). Dilutions of
the indicated primers were added to the reactions at
concentrations of 1nM to 5mM (with the concentration
rangedependingonthe lengthoftheprimer).The reactions
were incubated at 308C for 15min (which is within
the linear phase of the reaction) and then terminated
by adding 90ml of TES (50mM Tris–HCl pH 8.3,
20mM EDTA and 0.2% SDS). 5000cpm of a
32P-labelled 100-mer oligonucleotide was added as a
recovery and loading control. The reaction products
were phenol/chloroform extracted and ethanol precipi-
tated. The pellet was resuspended in 5ml of formamide
loading dye (90% deionized formamide, 0.1% bromophe-
nol blue, 0.1% xylene cyanol in 1  TBE buﬀer) and half
Table 1. Oligonucleotides used in this study
Name Sequence
18GGGG TTGGGGTTGGGGTTGGGG
18GGT TGGGGTTGGGGTTGGGGT
18GTT GGGGTTGGGGTTGGGGTT
18TTG GGGTTGGGGTTGGGGTTG
18TGG GGTTGGGGTTGGGGTTGG
18TGGG GTTGGGGTTGGGGTTGGG
20GTT TTGGGGTTGGGGTTGGGGTT
12GTT GGGGTTGGGGTT
6GTT GGGGTT
37TTG GGGGTTGGGGTTGGGGTTGGGGTTG
GGGTTGGGGTTG
PBR AGCCACTATCGACTACGCGATCAT
PBR48 AGCCACTATCGACTACGCGATCATAGC
CACTATCGACTACGCGATCAT
(TTAGGG)3 TTAGGGTTAGGGTTAGGG
All sequences are listed 50 to 30. Some oligonucleotides were
modiﬁed by addition of a biotin, on either the 50 (e.g. Bio-18GTT)
or the 30 (e.g. PBR48-Bio) end. 20GTT was modiﬁed by incorporation
of 5-iodo-deoxyuridine (Figure 5).
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polyacrylamide/8M urea sequencing-type gel for 1.25h at
80W. The gel was dried for 30min at 808C, exposed to a
phosphorimager screen and analysed using ImageQuant
5.2 software (Amersham Biosciences/GE Healthcare).
Total intensity of extension products at each substrate
concentration was normalized against the intensity of the
32P-labelled 100-mer loading control. This value was
expressed as percentage of maximum intensity at the
highest primer concentration and plotted against substrate
concentration. This was ﬁtted to a Michaelis–Menten
kinetics equation to yield Km.
Bind-and-chase activity assaytomeasure primer off-rates
A modiﬁed telomerase assay was used to measure the rate
of dissociation of primer from recombinant Tetrahymena
telomerase, as previously described (10). Telomeric
oligonucleotides of 18–20nt (Table 1) were preincubated
at a concentration of 200nM with 5ml of immunopuriﬁed
telomerase (1:1 bead slurry) in 1  Telomerase buﬀer at
308C for 15min. A 37-mer competitor primer (37GTT)
was added (ﬁnal concentration 15mM) and incubated with
the enzyme/primer mixture at 308C for varying lengths of
time (Figure 1). Telomerase activity was initiated by the
addition of nucleotides (either [a-
32P]dGTP at 10mM and
ddTTP at 100mMo r[ a-
32P]dTTP at 3.3mM and ddGTP
at 10mM, depending on the permutation of the primer)
and allowed to extend the primers at 308C for 5min.
The reactions were terminated and electrophoresed as
earlier. To determine koﬀ, the intensity of the 18–20-mer
products was quantiﬁed, normalized to the combined
intensities of all major extension products (18- and
37-mer) and plotted against time. The data were ﬁt to
the equation y=ae
 kt+b, where k=koﬀ and b repre-
sents a background in the experiment of about 5%.
The half life was calculated by using the equation
t½= {ln[(0.5 – b)/a]}/k.
DNA-binding assayto measureprimer binding toTERT
Oligonucleotides with a 50 biotin and PBR48 with a biotin
at the 30 end (Table 1) were synthesized and gel-puriﬁed
by Sigma-Genosys. UltraLink Immobilized NeutrAvidin
Protein Plus (Pierce) beads (200ml) were washed four
times in 1ml of Protein Pulldown (PP) buﬀer (50mM Tris
chloride, pH 8.3, 10% glycerol, 1.25mM MgCl2,5 m M
DTT), centrifuging at 1500 g for 2min at 48C between
washes. The beads were incubated twice with 0.5ml
of blocking buﬀer (PP buﬀer plus 0.75mg/ml BSA,
0.15mg/ml glycogen, 0.15mg/ml yeast RNA) for 15min
at 48C with agitation and resuspended in 100mlo f
blocking buﬀer. Primer binding of recombinant telomer-
ase was measured by incubating 2.5ml of eluted protein in
a Protein LoBind tube (Eppendorf) in a 20ml reaction
including 1  Telomerase buﬀer (see earlier), 2500cpm of
33P-labelled PBR48-Bio and the indicated primers at
concentrations of 1nM to 10mM (with the concentration
range depending on the length of the primer and
the fragment of protein). The reactions were incubated
at 308C for 10min, followed by the addition of 20ml
of blocked NeutrAvidin beads and agitation at 48C
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Primer koff (min−1) 30°Ct 1/2 (min)
18GGGG 1.3 ± 0.4 0.7 ± 0.2
18GGT 1.2 ± 0.2 0.7 ± 0.1
18GTT 1.16 ± 0.04 0.65 ± 0.02
18TTG 0.46 ± 0.08 1.6 ± 0.2
18TGG 0.39 ± 0.01 1.91 ± 0.04
18TGGG 0.52 ± 0.09 1.7 ± 0.4
20GTT 0.89 ± 0.08 0.8 ± 0.1
Time (min)
Figure 1. Rate of dissociation from recombinant Tetrahymena telomerase of DNA primers of diﬀerent permutations. (A) A bind-and-chase
telomerase activity assay (described in the text) was used to measure the dissociation of primer 18GTT (Table 1). The pattern of extension of 18GTT
and the chase primer 37TTG alone, when incubated with ddTTP and [a-
32P]dGTP, are shown in the ﬁrst two lanes. As a control to ensure that the
excess of 37TTG did not allow the enzyme to rebind the 18GTT, both primers were preincubated with enzyme simultaneously prior to telomerase
extension (‘chase control’). LC:
32P-labelled 100-mer DNA oligonucleotide used as a recovery and loading control. (B) The amount of signal from
products of 18GTT was normalized to the total telomerase product signal and plotted versus time of chase. Two experiments utilizing the same
primer (18GTT) are shown. (C) The curves shown in B were ﬁt with a single exponential equation (see ‘Experimental Procedures’) to give the oﬀ-rate
(koﬀ) and half-life (t1/2) of a set of 18 or 20nt oligonucleotides of diﬀerent permutations (Table 1). The mean SD of two to four experiments is
shown.
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four times (1500 g for 2min at 48C) in 100ml of PP-300
buﬀer (PP buﬀer plus 300mM lithium acetate; lithium was
used to minimize formation of intermolecular G-quad-
ruplexes) and ﬁnally resuspended in 20ml of PP-300 buﬀer
and 10ml of NuPage 4  Lithium dodecyl sulfate (LDS)
Sample Buﬀer (Invitrogen) and heated at 958C 3min.
Half of each reaction was electrophoresed on 4–12%
NuPage gels in MES [2-(N-morpholino) ethane sulfonic
acid] buﬀer (Invitrogen) for 35min at 200V. The gels were
ﬁxed for 15min in 25% isopropanol/10% acetic acid,
dried at 808C for 1h and exposed to a phosphorimager
screen.Totalintensity of protein captured ateach substrate
concentration was normalized against the intensity of the
33P-labelled PBR48-Bio loading control. The signal from
the sample with no oligonucleotide, representing back-
ground binding to the beads, was subtracted from all
others. The resulting value was expressed as percentage of
maximumintensityatthehighestprimerconcentrationand
plotted against substrate concentration [S]. This was ﬁtted
to the following equation: y=(Bmax [S])U(Kd+[S]),
where Bmax is the maximal level of binding, to yield Kd.
Crosslinking of5-iodo-dU substituted primers to TERT
20GTT oligonucleotides with 5-iodo-deoxyuridine in
one of four positions (Figure 5A) were synthesized and
gel-puriﬁed by Sigma-Genosys. The oligonucleotides were
50-end-labelled with T4 polynucleotide kinase (New
England Biolabs) and unincorporated nucleotides were
removed by puriﬁcation on a Mini Quick Spin Oligo
column (Roche Applied Science). Labelled oligonucleo-
tides (15–100nM) were incubated with unlabelled in vitro
translated, immunopuriﬁed and eluted TERT or fragment
of TERT ( 3–4nM) in 1  Telomerase buﬀer (see earlier)
for 10min at 308C. Reactions contained either no
competitor or 5mM unlabelled speciﬁc (20GTT) or non-
speciﬁc (PBR) competitor oligonucleotide, as indicated.
Reactions were dispensed onto a paraﬁlm-covered alumi-
nium block sitting on ice, covered with a 4-mm thick
313 3nm bandpass optical ﬁlter (Andover Corporation)
and crosslinked in a Stratalinker (Stratagene) with 312nm
bulbs (UviTec) for 45min. After crosslinking, reactions
were electrophoresed on 4–12% NuPage gels in MES
buﬀer (Invitrogen) for 35min at 200V. The gels were ﬁxed
for 15min in 25% isopropanol/10% acetic acid, dried at
808C for 1h and exposed to a phosphorimager screen.
For the experiment in Figure 5F,
35S-labelled proteins
were used. A piece of X-ray ﬁlm was placed between
the gel and phosphorimager screen to shield signal from
35S-labelled protein and leave only signal from
32P-labelled DNA (upper panel). A second exposure was
obtained with no X-ray ﬁlm to ensure equal loading of
protein (bottom panel).
For the experiment in Figure 6B, in vitro translated
TERT was replaced with the TEN domain of TERT that
had been bacterially expressed and puriﬁed as described
(29) and which was a gift from Drs Steven Jacobs and
Thomas Cech. These crosslinking reactions were carried
out in the presence of 5mM non-speciﬁc competitor
(PBR).
Immunoprecipitation to measureRNA bindingto TERT
FLAG-tagged fragments of TERT were tested for their
ability to immunoprecipitate telomerase RNA as
described (39) with the exceptions that anti-FLAG M2
aﬃnity agarose beads (Sigma-Aldrich) were used, and the
reactions were electrophoresed on 4–12% NuPage gels
(Invitrogen).
RESULTS
Recombinant Tetrahymena telomerase dissociates equally
from primers withdifferent 3’ ends
It has been shown that DNA primers dissociate from
endogenous human telomerase at diﬀerent rates, depend-
ing on the permutation of the 30 end of the primer (40).
Primers ending in GGG displayed half-lives of greater
than 20h at room temperature. In order to determine the
best primer to use for binding experiments, we sought to
determine whether the same is true for recombinant
Tetrahymena telomerase. We used an activity-based bind-
and-chase assay for primer dissociation that we previously
developed (10). In this assay, telomerase was allowed to
form a complex with a short (18–20nt) DNA primer of
telomeric sequence. A 75-fold excess of a longer primer
(37nt) was added and incubated with the enzyme/primer
mixture at 308C for varying lengths of time. Telomerase
activity was then initiated by addition of nucleotides
(either ddTTP and [a-
32P]dGTP, or [a-
32P]dTTP and
ddGTP, depending on the permutation of the primer) and
allowed to proceed at 308C for 5min. The inclusion of
ddTTP or ddGTP resulted in termination of extension
after incorporation of the ﬁrst T or G respectively,
generating 2 to 5 product bands, depending on the
permutation of the primer (Figure 1A and B, illustrated
for primer 18GTT). To establish that the excess of longer
primer did not allow the enzyme to rebind 18-mer, both
primers were preincubated simultaneously with enzyme,
which eliminated extension of the 18-mer (Figure 1A,
chase control lane). Thus, the amount of addition to
18GTT after varying lengths of chase time is a reﬂection of
the amount of the original primer still bound to enzyme at
that time. We observed similar dissociation rates for all six
primer permutations; koﬀ ranged from 0.39 to 1.3min
 1,
corresponding to half lives of 0.7 to 1.9min at 308C
(Figure 1C). Thus recombinant Tetrahymena telomerase,
like endogenous Euplotes aediculatus telomerase (41), does
not show the large ( 100-fold) diﬀerences in primer
aﬃnities that were observed for endogenous human
telomerase. Since 18GTT has been the standard primer
in our telomerase assays (10,39), we chose to use this
primer for the primer binding assay described later.
Development ofadirect equilibrium bindingassay for
measuring TERT–primer interactions
Previous studies examining the interaction of telomerase
with DNA have relied on measurement of telomerase
activity (10,17,35) or crosslinking of modiﬁed oligonucleo-
tides (20–22,24). We sought to develop a quantitative
activity-independent equilibrium binding assay for
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measure DNA-binding aﬃnities of TERT protein
domains. We developed a simple assay in which puriﬁed
35S-labelled in vitro-translated TERT is bound to increas-
ing concentrations of biotinylated 18GTT and the
resulting TERT–DNA complex is captured on
NeutrAvidin beads. Products are analyzed by PAGE to
visualize the amount of TERT that is recovered with
the beads. A
33P-labelled biotinylated primer of random
sequence (PBR48-Bio; Table 1) is used as an internal
recovery and loading control. A similar assay was recently
independently reported, with the diﬀerence that that
assay used unpuriﬁed enzyme and a single, presumably
saturating concentration of DNA primer (36). Rabbit
reticulocyte lysates contain proteins that eﬃciently bind
telomeric oligonucleotides (our unpublished data), so a
key requirement to quantitatively measure telomerase
binding aﬃnities is to purify the enzyme.
Binding of recombinant TERT to Bio-18GTT resulted
in a dissociation constant (Kd)o f8  2nM (Figure 2A
and C), which is comparable to that of telomerase puriﬁed
from Tetrahymena extracts (20–30nM for an 18nt primer,
ref. 11 and our unpublished data) despite the higher
processivity of the latter.
As a control for non-speciﬁc DNA binding in all
experiments, a biotinylated non-telomeric primer was
used for the pull-down (Bio-PBR; Table 1); binding to
this primer was not apparent above the background levels
that are observed in the absence of primer (Figure 2A).
Binding of Tetrahymena TERT to the human telomeric
sequence (TTAGGG)3 was also not apparent above
background levels (Supplementary Figure); thus this
assay shows exquisite speciﬁcity for the Tetrahymena
telomeric sequence, TTGGGG. Tetrahymena telomerase
does have the capability to extend other sequences (18),
but the aﬃnity of such interactions is low ( 1mM for
(TTAGGG)3,  8mM for Bio-PBR; data not shown) and
is presumably beyond the detection limits of our primer
binding assay.
To determine whether the binding observed in the
DNA-binding assay reﬂects active telomerase, we also
determined the Km of the same puriﬁed recombinant
enzyme in a direct telomerase primer extension assay
(Figure 2B). The biotinylated and non-biotinylated ver-
sions of 18GTT displayed similar Kms, which were not
signiﬁcantly diﬀerent from the Kd as measured by the
DNA-binding assay (Table 2 and Figure 2C), indicating
that the binding we observe reﬂects active primer–enzyme
complexes.
Tetrahymena telomerase binds DNA inalength-dependent
andRNA-independent manner
It has been demonstrated for endogenous Tetrahymena
telomerase that the Km increases in a stepwise manner as
the primer gets shorter, reﬂecting loss of binding sites in
diﬀerent regions of the primer (11). We also observed that
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Figure 2. A DNA-binding assay to directly measure DNA primer aﬃnity to telomerase. (A) The indicated concentrations of biotinylated telomeric
(18GTT) oligonucleotide or 250nM non-telomeric control (Bio-PBR) were incubated with
35S-labelled full-length recombinant telomerase
(TERT+RNA) and recovered on NeutrAvidin beads. ‘Input’ represents 20% of the starting material in the bound lanes. LC:
33P-labelled PBR48-
Bio oligonucleotide, used as a loading and recovery control. (B) Primer extension activity of puriﬁed recombinant Tetrahymena telomerase, using
biotinylated or non-biotinylated 18GTT primer at the indicated concentrations. ‘n+1’ is the ﬁrst nucleotide added to each primer; ‘LC’ is a
32P-labelled 100-mer DNA oligonucleotide used as a recovery and loading control. (C) Binding or activity were quantiﬁed from gels such as those in
A and B, and normalized to the highest value. Filled square, binding of Bio-18GTT to telomerase; ﬁlled circle, activity using Bio-18GTT; open
square, activity using 18GTT. The mean of three to four independent experiments is plotted; error bars=SD.
Nucleic Acids Research, 2008, Vol. 36, No. 4 1265both the Km and the Kd increased with a 12nt primer
(Table 2). Within experimental error, the Kd for this 12nt
primer also reﬂects the Km (it should be noted that the
error inherent in these assays is large when dealing with
low-aﬃnity interactions with high rates of dissociation).
Decreasing the length of the telomeric primer to 6nt
resulted in a further increase in Km of 1–2 orders of
magnitude (Table 2). There was no detectable binding
of TERT to this primer using the DNA-binding assay.
Primers of 4 or 5nt, which can be extended by
Tetrahymena telomerase (19) with Kms of 1–2mM
(data not shown), also showed no detectable binding in
our assay (data not shown). Since this assay involves
washing the beads after binding, low-aﬃnity interactions
with high oﬀ-rates are not detectable. Thus we put an
upper limit on Kd measurement for this assay of between
300 (see later) and 900nM.
It has been reported that yeast and Tetrahymena
telomerase are dependent on the telomerase RNA subunit
for crosslinking to a DNA primer (22,24). We found
that binding of TERT to 18GTT DNA in our binding
assay was only partially dependent on the RNA
(Figure 3). The Kd for this interaction was 29 5nM,
3–4-fold greater than that in the presence of RNA. Under
these reconstitution conditions, about 50% of TERT
protein in the +RNA samples is not bound to telomerase
RNA (37), so the actual diﬀerence in binding aﬃnities
may be somewhat greater than 3–4-fold. Nevertheless,
these data clearly show that telomerase RNA contributes
to, but is not completely necessary for, binding of
Tetrahymena telomerase to a DNA primer.
DNA–proteininteractionsexistinmultipledomainsofTERT
We utilized the DNA-binding assay to explore binding
of DNA to domains of the TERT protein. A fragment
consisting of the N-terminal half of the protein, which
includes several TERT-speciﬁc motifs, bound to 18GTT
with a  6-fold reduction in aﬃnity over full-length protein
(N519, Figure 4). In contrast, the C-terminal half of
TERT, encompassing the RT motifs, bound to 18GTT
with an aﬃnity almost equal to full-length TERT (C598,
Figure 4). Binding to each of the fragments in Figure 4
was speciﬁc for telomeric DNA, since the oligonucleotide
Bio-PBR showed only background levels of binding
(data not shown). Thus there are speciﬁc high-aﬃnity
binding sites in both halves of TERT, especially the
C-terminal half. It is not possible to conﬁrm that the same
binding sites would be used in the context of an active
enzyme, since these fragments of TERT are inactive,
but the speciﬁcity and high aﬃnity of the interactions
point to their biological relevance.
Deletion of the C-terminal 233 amino acids, which are
unique to TERT, resulted in a modest increase in Kd of
about 4-fold (C233, Figure 4), indicating that the RT
motifs likely play a signiﬁcant role in the high-aﬃnity
primer binding of the C-terminal half of the protein.
We also made a version of TERT lacking the C-terminal
23 amino acids; this mutant completely lacked telomerase
activity (data not shown), but again showed only a
modest decrease in primer binding aﬃnity (C23,
Figure 4). Thus the extreme C-terminus of Tetrahymena
TERT has an essential role in telomerase activity, which
may include, but is probably not limited to, interactions
with the DNA primer. This result illustrates the impor-
tance of a quantitative equilibrium binding assay for
Table 2. Km and Kd of oligonucleotides of various lengths
Primer Km (nM) Kd (nM)
Bio-18GTT 12 78  2
18GTT 8 3 n/a
Bio-12GTT 22 7 160 140
12GTT 60 50 n/a
Bio-6GTT 900 1200 n.d.
6GTT 1900 500 n/a
Km was determined using direct telomerase activity assays at diﬀerent
concentrations of primer, and Kd was determined using the DNA
immobilization assay at diﬀerent concentrations of primer. Mean SD
is shown (n=3 to 4). n/a, not applicable, since a biotin tag is necessary
for the DNA immobilization assay. n.d., not detectable up to 10mM
primer.
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Figure 3. DNA interacts with telomerase independently of telomerase
RNA. (A) The indicated concentrations of biotinylated 18GTT
oligonucleotide were incubated with
35S-labelled full-length recombi-
nant TERT (-telomerase RNA) and recovered on NeutrAvidin beads.
‘Input’ represents 20% of the starting material in the bound lanes. LC:
33P-labelled PBR-48-Bio oligonucleotide, used as a loading and
recovery control. (B) Quantiﬁcation of data in A, together with that
in Figure 2A, to show increase in Kd in the absence of telomerase
RNA. Filled square, binding of Bio-18GTT to TERT+RNA, ﬁlled
circle, binding of Bio-18GTT to TERT–RNA. The mean of three to
four independent experiments is plotted; error bars=SD.
1266 Nucleic Acids Research, 2008, Vol. 36, No. 4assessing the extent of the contribution to DNA binding
of regions of TERT.
TERT–DNA binding isdirect
To conﬁrm that the binding to the TERT protein and
its fragments is direct rather than mediated through a
copurifying protein, we utilized UV crosslinking to
5-iodo-dU substituted oligonucleotides. We used a 20nt
telomeric oligonucleotide (20GTT; Table 1) that has a
similar oﬀ-rate from telomerase to that of 18GTT
(Figure 1C). In an attempt to probe for crosslinks between
DNA and TERT at diﬀerent positions along the DNA
primer, we used a set of four primers, each of which had
one substitution (Figure 5A). When
32P-labelled oligonu-
cleotide was exposed to 312nm light in the presence of
unlabelled immunopuriﬁed telomerase and electrophore-
sed on PAGE gels, a band the size of TERT (125kDa) was
observed (Figure 5B). Speciﬁcity was demonstrated by the
fact that this band was competed by an excess of telomeric
primer (20GTT), but was only minimally competed by a
non-telomeric primer (PBR; see Table 1). Some competi-
tion from PBR was expected, since Tetrahymena telomer-
ase has a limited ability to extend non-telomeric primers
(18); the Km for PBR is  8mM (data not shown).
Crosslinking of all four substituted primers was observed.
The telomeric primer also crosslinked to proteins of a
diﬀerent size than full-length TERT (Figure 5B); some of
these interactions are clearly non-speciﬁc, but the speciﬁc
ones may be due either to crosslinking to a protein that
copuriﬁes with TERT, or to incomplete translation
products of TERT.
At this concentration of DNA (15nM), crosslinking
was reduced in the absence of telomerase RNA
(Figure 5B), which is consistent with the increased Kd of
TERT in the absence of telomerase RNA (Figure 4).
We used the same four primers to conﬁrm binding
of DNA to the fragments of TERT discussed earlier.
Surprisingly, all four primers also crosslinked speciﬁcally
to N519 and C598, so we were unable to determine which
region of the protein interacts with which nucleotide of the
primer (Figure 5C and D).
Cooperative binding inthe N-terminal half ofTERT
A region encompassing the ﬁrst 191 amino acids of
Tetrahymena TERT forms a soluble, independently folded
domain that is essential for telomerase activity and
crosslinks to a telomeric DNA primer (24,29). In our
DNA-binding assay using
35S-labelled in vitro translated
protein, there was no detectable binding above back-
ground levels of this fragment (the TEN domain) to
18GTT (Figure 6A). Binding of 18GTT to TERT that is
missing this domain (TEN) resulted in an increase in
Kd of only about 4-fold (Figure 4), despite the fact
that TEN completely lacks telomerase activity (29). This
suggests that the TEN domain, alone, does not provide
signiﬁcant binding aﬃnity for the DNA primer.
To conﬁrm this ﬁnding, we also utilized UV crosslinking
of 5-iodo-dU substituted oligonucleotides to this fragment.
At the low protein concentrations which we are able to
produce from in vitro translation ( 7–9nM), there was no
detectable crosslinking to this fragment (data not shown).
However, when we crosslinked the same four primers
to high concentrations (80nM–20mM) of TEN protein
puriﬁed from E. coli, we were able to detect crosslinking
speciﬁc for telomeric DNA, as previously reported
(Figure 6B, data not shown and ref. 24). Titration of the
TEN protein gave a Kd of  550nM for this interaction
(Figure 6B), which is presumably beyond the detection
limit of our DNA-binding assay. It has previously
been demonstrated that the TEN domain also crosslinks
to DNA in the context of the full-length protein,
T2/N/GQ CP2 CP QFP T 12 A B′ CD E
TERT-specific motifs RT motifs
FL-TERT
N519
C598
TEN
RBD
Kd (nM)
+RNA −RNA
8 ± 2
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29 ± 5
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8 ± 2
93 ± 30
14 ± 4  19 ± 22
550 ± 250*
330 ± 100 240 ± 70
31 ± 3 24 ± 1
33 ± 6 42 ± 1
23 ± 3
(1-1117)
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(2-191)
(192-519)
(192-1117)
(1-884)
(1-1094)
Figure 4. Summary of binding of oligonucleotide Bio-18GTT to fragments of TERT. At the top is a representation of Tetrahymena thermophila
TERT, with conserved protein motifs shown as coloured boxes. The names of the fragments and the amino acids of TERT which they encompass are
shown on the left. On the right are the binding constants of DNA and TERT in the presence or absence of telomerase RNA (mean SD).
 This Kd
was measured using crosslinking; n.d.=not determined.
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Figure 5. Crosslinking of 5-iodo-deoxyuridine substituted 20GTT to TERT and fragments of TERT. (A) Sequence of the four oligonucleotides used
for crosslinking in B–F;
IU=5-iodo-deoxyuridine. (B)
32P-labelled DNA (15nM) was crosslinked to full-length TERT in the absence of competitor
or in the presence of a 333-fold excess of cold telomeric (20GTT) or non-telomeric (PBR) competitor primer. Crosslinking was carried out in the
presence or absence of telomerase RNA. (C)
32P-labelled DNA (90nM) was crosslinked to N519 in the absence of competitor or in the presence of a
55-fold excess of cold telomeric (20GTT) or non-telomeric (PBR) competitor primer. (D)
32P-labelled DNA (15nM) was crosslinked to C598 in the
absence of competitor or in the presence of a 333-fold excess of cold telomeric (20GTT) or non-telomeric (PBR) competitor primer. (E)
32P-labelled
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32P and
35S-labelled proteins, to ensure the use of an equimolar mixture of proteins.
1268 Nucleic Acids Research, 2008, Vol. 36, No. 4since crosslinking to an equimolar mixture of full-length
and TEN proteins resulted in a greater extent of cross-
linking to the full-length protein (24). We conﬁrmed this
ﬁnding, and determined that this was also the case for all
four of our substituted oligonucleotides (Figure 5F).
The region encompassing amino acids 192–519 of
Tetrahymena TERT is able to independently bind to
telomerase RNA (34). This region, the RNA binding
domain (RBD), was also able to bind to DNA oligonu-
cleotides in both the DNA binding (Figure 4)
and crosslinking (Figure 5E) assays, although the aﬃnity
was quite low ( 330nM). Thus the RBD and TEN
domains each show low-aﬃnity interactions with DNA,
although in combination (as in fragment N519) they
demonstrate relatively high-aﬃnity binding. This suggests
that these two fragments act cooperatively to bind DNA
in the context of the full-length protein. It is also possible
that a high-aﬃnity site at the boundary of these two
regions has been disrupted, although addition of an extra
four amino acids to the C-terminal end of the TEN
domain did not restore binding in our assay (data not
shown). There is evidence that these amino acids mark the
boundary of a discrete structural domain (29) and beyond
this is an unstructured, ﬂexible linker (28,42).
To conﬁrm the structural integrity of the RBD
domain and other protein fragments used in our study,
we measured their ability to interact with telomerase RNA
(Figure 7). RNA interaction was measured by immuno-
precipitation of
32P-labelled telomerase RNA with
35S-labelled protein. As previously reported (34,39,43),
N519 and RBD showed a robust ability to immunopre-
cipitate RNA, whereas C598 did not show any detectable
binding. The TEN and C233 proteins also bound
telomerase RNA, indicating that the RNA binding
region of these proteins is correctly folded. The TEN
domain showed very weak binding to telomerase RNA,
as previously reported (43).
DISCUSSION
The ability of telomerase to interact with DNA at sites
outside its catalytic centre is important for its unique
ability to undergo repeat addition processivity. There
have now been a number of studies localizing diﬀerent
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Nucleic Acids Research, 2008, Vol. 36, No. 4 1269DNA-binding regions of the TERT protein. What is
unique about this study is our ability to directly and
quantitatively measure DNA-binding aﬃnities indepen-
dent of activity, which has provided insight into the
relative contributions of diﬀerent regions of TERT.
It should be borne in mind that the actual aﬃnities of
isolated regions may diﬀer to those in the complete
enzyme, since there are likely to be complex interactions
and cooperativity between TERT, DNA and telomerase
RNA in the latter context. Indeed, our data reveal some of
this complexity. However, it is clear that together, these
sites contribute to very speciﬁc and high-aﬃnity DNA
binding by recombinant Tetrahymena telomerase, with a
Kd of  8nM. Both the Km and Kd increased when
the primer length was reduced from 18 to 12nt, and
underwent a further increase of 1–2 orders of magnitude
upon a reduction in primer length to 6nt. This suggests
that recombinant Tetrahymena telomerase, like the
endogenous enzyme, contains multiple anchor sites.
Indeed, the aﬃnity of recombinant Tetrahymena telome-
rase for an 18nt primer was similar to that of extract-
derived telomerase (11, and our unpublished data), despite
the much higher processivity of the latter. There are
two possible explanations for this apparent paradox.
First, it is possible that recombinant telomerase may have
a faster primer on-rate as well as a faster primer oﬀ-rate
than endogenous telomerase; this may lead to a similar
overall Kd. Secondly, it has been noted that there appear
to be two populations of extension products of endoge-
nous Tetrahymena telomerase, corresponding to the
addition to the primer of a few repeats or many repeats
respectively (11,12); the latter result from decreasing
probability of product dissociation with increasing
product length above 30–50nt (11). Thus the endogenous
Tetrahymena telomerase complex may possess yet another
‘anchor site’, provided by a protein other than TERT that
interacts with very long products, that may not aﬀect
the aﬃnity of endogenous telomerase for short (e.g. 18nt)
DNA primers.
Previous studies have concluded that a region encom-
passing the ﬁrst 200 amino acids of TERT (the TEN or
GQ domain) is an important component of the telomerase
anchor site (17,22–24,35,36). However, quantitative
analysis shows that this region possesses relatively low-
binding aﬃnity, two orders of magnitude lower than that
of the full-length protein. This domain had the lowest
aﬃnity for DNA of all the regions that we tested. This
might be expected when analyzing the TEN domain
protein in isolation, but the fact that the TEN protein
showed only a modest decrease in primer-binding aﬃnity
relative to full-length protein indicates that TEN does not
provide much of the overall aﬃnity for DNA primer in the
context of the full-length protein. While the interactions of
TEN with DNA may be crucially important for proper
alignment or movement of the primer, they clearly are not
necessary for maintaining tight binding to DNA, and
hence may only constitute a minor part of the telomerase
anchor sites.
Amino acids 1–300 of human TERT, encompassing the
TEN domain, were able to be captured by biotinylated
telomeric oligonucleotides in an assay similar to that used
here (36). Possible reasons for this apparent discrepancy
with our results include: (i) species diﬀerences in TEN
function, (ii) the fact that a longer region of the protein
was tested or (iii) the fact that the Wyatt et al. study used a
high concentration of DNA, which may have allowed
detection of a weak interaction.
In the context of the full-length protein, the
Tetrahymena TEN region may contribute to DNA
binding cooperatively with the RBD, since a protein
encompassing both of these fragments showed much
higher DNA binding than either fragment alone
(Figure 4). Such cooperativity would be consistent with
the observed functional interactions between the TEN
domain and the rest of the protein (30–32).
Notwithstanding the above discussion, it is clear that
the Tetrahymena TEN domain interacts with the DNA
primer (23,24). The question remains, with which part of
the primer is it interacting, i.e. if it does in fact constitute a
telomerase anchor site, is it the template-proximal or the
template-distal anchor site? The study by Romi et al. (23)
is unique in that it involved crosslinking of the DNA
primer, followed by extension of the primer by telomerase
using radiolabelled nucleotides; thus any signal obtained
must be due to DNA molecules with their 30 end in
the active site of the enzyme. Crosslinking was observed
with DNA primers substituted in a position that is within
the template-binding region; this indicates that the
Tetrahymena TEN domain is close to a very template-
proximal region of the primer. Studies with human and
yeast TERT also suggest that the TEN domain interacts
with a template-proximal part of the primer (17,22).
On the other hand, mutations in Tetrahymena TERT
disrupted crosslinking to nucleotides far upstream of the 30
end of the primer (24) and in fact substitutions at any of
four positions throughout a primer support crosslinking
of the primer to the TEN domain either in isolation (data
not shown), or in the context of the full-length protein
(Figure 5F). It is possible that in the latter two
studies, crosslinking is reﬂecting stable non-productive
interactions between primer and enzyme such that the 30
end of the primer is not aligned with the active site.
However, the prevalence of these interactions would be
inconsistent with the very low Kd that we observe between
full-length TERT and the primer, and also with the fact
that some of the amino acids involved in mediating
the crosslinking reaction are also important for activity
(24). An alternative scenario to reconcile these data could
be that initial binding of the primer to its speciﬁc binding
sites within TERT can occur in any of the ‘registers’ of
repeat binding, and it is these events that are captured by
crosslinking; this is followed by rapid sliding of the DNA
to position its 30 end to be close to the TEN domain and
the enzyme active site.
The data in Figure 4 suggest that a minimum of
four discrete DNA-interaction sites (in the TEN, RBD,
RT and C-terminal domains) exist. The actual number
of binding sites is potentially much higher than four.
These data directly conﬁrm some interactions that have
been inferred based on activity assays, and add a novel
function of the RNA-binding region of TERT to DNA
binding, which has also recently been suggested based
1270 Nucleic Acids Research, 2008, Vol. 36, No. 4on crosslinking (23). Binding to the RBD was independent
of the presence of telomerase RNA (Figure 4), indicating
that this domain has two separable functions. Although
the TEN domain may contribute to the template-proximal
anchor site, the template-distal anchor site remains to
be localized, despite ample evidence for its existence
(11,13–15,19); this site may reside in any of the RBD,
RT or C-terminal domains.
Previous studies have concluded that binding of a DNA
primer to telomerase is greatly increased by the presence
of telomerase RNA (22,24). On the other hand, RNA-
independent binding of human TERT to DNA has
recently been reported (36). The present study, due to its
quantitative nature, suggests that the RNA component
has only a modest impact on binding of DNA to full-
length TERT; this result would be expected in the presence
of several protein anchor sites. It is possible that the
RNA-independent binding we observe does not comple-
tely reﬂect interactions that would occur in the context of
the intact enzyme, though the speciﬁcity of the interaction
(Figure 3A) argues against this. The RNA may positively
impact on DNA binding solely through its base-pairing
interactions with the primer, or possibly by also inducing
a protein conformational change. Only the primer Kd
of full-length protein was substantially aﬀected by the
RNA; this would be expected since the C598 fragment
does not show high-binding aﬃnity for the RNA, and the
N519 fragment lacks the active site of the protein, which is
where a base-pairing interaction or putative protein
conformational change would occur.
An intriguing aspect of our data is that the C598
fragment of TERT binds to DNA with an aﬃnity equal
to full-length protein, while the N-terminal half of the
protein also binds to DNA with an aﬃnity just 6-fold
lower than full-length protein. This suggests that both
N- and C-terminal halves of the protein contain multiple
binding sites, not all of which are used simultaneously in
the context of the full-length protein. Binding contributed
by each half of the protein must be independent, since
cooperative binding would likely lead to a DNA-binding
aﬃnity by the full-length protein even greater than that
observed. In the context of binding to telomerase RNA,
the two halves of the protein also demonstrate indepen-
dence in that the N-terminal half is necessary and
suﬃcient for binding (Figure 7 and ref. 39). We propose
that diﬀerent DNA-binding sites are used by the enzyme
during diﬀerent stages of the six nucleotide addition cycle,
since the DNA must move relative to the enzyme as each
nucleotide is added.
Our data not only conﬁrm that DNA-binding sites are
located in multiple regions of the TERT protein, but also
suggest that binding to these sites may be more complex
than previously envisaged. It is possible that the DNA
moves relative to the diﬀerent sites while preparing for
extension; it is also possible that diﬀerent sites interact
with DNA at diﬀerent stages of the addition cycle. Also,
there may be cooperativity in DNA binding between
diﬀerent regions of the TERT protein. Thus there remains
much to be learned about the nature of the telomerase
anchor sites.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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